Polyrizon’s Insiders Bet Big: Executives Hold Vested Stakes as Company Prepares for 2026 Human Trials
Polyrizon insiders’ long‑term holdings signal confidence in its nasal hydrogel and upcoming human trials—investors should watch for milestone-driven value.
4 minutes to read